APOE4 derived from astrocytes leads to blood-brain barrier impairment.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
21 10 2022
Historique:
received: 20 07 2021
revised: 25 10 2021
accepted: 01 12 2021
pubmed: 28 12 2021
medline: 26 10 2022
entrez: 27 12 2021
Statut: ppublish

Résumé

Apolipoprotein E (ApoE) is a multifaceted secreted molecule synthesized in the CNS by astrocytes and microglia, and in the periphery largely by the liver. ApoE has been shown to impact the integrity of the blood-brain barrier, and, in humans, the APOE4 allele of the gene is reported to lead to a leaky blood-brain barrier. We used allele specific knock-in mice expressing each of the common (human) ApoE alleles, and longitudinal multiphoton intravital microscopy, to directly monitor the impact of various ApoE isoforms on blood-brain barrier integrity. We found that humanized APOE4, but not APOE2 or APOE3, mice show a leaky blood-brain barrier, increased MMP9, impaired tight junctions, and reduced astrocyte end-foot coverage of blood vessels. Removal of astrocyte-produced ApoE4 led to the amelioration of all phenotypes while the removal of astrocyte-produced ApoE3 had no effect on blood-brain barrier integrity. This work shows a cell specific gain of function effect of ApoE4 in the dysfunction of the BBB and implicates astrocyte production of ApoE4, possibly as a function of astrocytic end foot interactions with vessels, as a key regulator of the integrity of the blood-brain barrier.

Identifiants

pubmed: 34957486
pii: 6484505
doi: 10.1093/brain/awab478
pmc: PMC9586546
doi:

Substances chimiques

Apolipoprotein E4 0
Apolipoprotein E3 0
Matrix Metalloproteinase 9 EC 3.4.24.35
Protein Isoforms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3582-3593

Subventions

Organisme : NIA NIH HHS
ID : T32 AG000222
Pays : United States
Organisme : NIA NIH HHS
ID : K99 AG061259
Pays : United States
Organisme : NIA NIH HHS
ID : R00 AG047336
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG047644
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Nature. 2020 Jul;583(7816):425-430
pubmed: 32612231
Stroke. 2012 Feb;43(2):514-23
pubmed: 22116809
Alzheimers Dement. 2018 Dec;14(12):1640-1650
pubmed: 30120040
Int J Mol Sci. 2020 Sep 01;21(17):
pubmed: 32882843
Nature. 2020 Jun;582(7810):89-94
pubmed: 32483373
Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006312
pubmed: 22393530
Nature. 2012 May 16;485(7399):512-6
pubmed: 22622580
Mol Neurodegener. 2018 Apr 4;13(1):17
pubmed: 29618365
Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1305-15
pubmed: 27174096
Mol Med. 2001 Dec;7(12):810-5
pubmed: 11844869
J Cereb Blood Flow Metab. 2016 Jan;36(1):216-27
pubmed: 25757756
Int J Mol Sci. 2019 Jan 29;20(3):
pubmed: 30699952
Nature. 2020 May;581(7806):71-76
pubmed: 32376954
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
J Vis Exp. 2015 Nov 10;(105):e53208
pubmed: 26574794
Neurosci Lett. 2019 Aug 24;708:134306
pubmed: 31181302
J Med Chem. 2019 Apr 25;62(8):4120-4130
pubmed: 30933499
Acta Neuropathol Commun. 2020 Aug 18;8(1):137
pubmed: 32811565
J Clin Invest. 1991 Jul;88(1):270-81
pubmed: 2056122
Neuron. 2017 May 3;94(3):581-594.e5
pubmed: 28416077
Biol Psychiatry. 2018 Feb 15;83(4):347-357
pubmed: 28434655
J Lipid Res. 2017 May;58(5):824-836
pubmed: 28246336
J Exp Med. 2021 Apr 5;218(4):
pubmed: 33533918
Neuron. 2010 Nov 4;68(3):409-27
pubmed: 21040844
Neuron. 2021 May 19;109(10):1657-1674.e7
pubmed: 33831349
Nat Rev Neurol. 2018 Mar;14(3):133-150
pubmed: 29377008
Br J Pharmacol. 2014 Mar;171(5):1210-30
pubmed: 24641185
J Am Coll Cardiol. 2020 Mar 3;75(8):942-951
pubmed: 32130930
Nature. 2020 Jul;583(7817):590-595
pubmed: 32669714
J Biol Chem. 2011 May 20;286(20):17536-42
pubmed: 21471207
J Biol Chem. 2021 Jan-Jun;296:100715
pubmed: 33930462
Mol Neurodegener. 2019 Oct 17;14(1):37
pubmed: 31623648
FEBS J. 2015 Nov;282(21):4067-79
pubmed: 26277326
Oncotarget. 2017 Jun 20;8(25):39941-39942
pubmed: 28537920
Sci Transl Med. 2013 Nov 20;5(212):212ra161
pubmed: 24259049
Glia. 2021 Jun;69(6):1478-1493
pubmed: 33556209
Nat Aging. 2021 Mar;1(3):243-254
pubmed: 34368785
PLoS Biol. 2015 Oct 29;13(10):e1002279
pubmed: 26512759
Trends Endocrinol Metab. 2017 Apr;28(4):273-284
pubmed: 28057414
Neuron. 2014 May 7;82(3):603-17
pubmed: 24746419

Auteurs

Rosemary J Jackson (RJ)

Alzheimer Research Unit, The Massachusetts General Hospital Institute for Neurodegenerative Disease, Charlestown, MA, USA.
Department of Neurology, The Massachusetts General Hospital and NeuroDiscovery Center, Harvard Medical School, Boston, MA, USA.

Jonah C Meltzer (JC)

Alzheimer Research Unit, The Massachusetts General Hospital Institute for Neurodegenerative Disease, Charlestown, MA, USA.
Department of Neurology, The Massachusetts General Hospital and NeuroDiscovery Center, Harvard Medical School, Boston, MA, USA.

Huong Nguyen (H)

Alzheimer Research Unit, The Massachusetts General Hospital Institute for Neurodegenerative Disease, Charlestown, MA, USA.
Department of Neurology, The Massachusetts General Hospital and NeuroDiscovery Center, Harvard Medical School, Boston, MA, USA.

Caitlin Commins (C)

Alzheimer Research Unit, The Massachusetts General Hospital Institute for Neurodegenerative Disease, Charlestown, MA, USA.
Department of Neurology, The Massachusetts General Hospital and NeuroDiscovery Center, Harvard Medical School, Boston, MA, USA.

Rachel E Bennett (RE)

Alzheimer Research Unit, The Massachusetts General Hospital Institute for Neurodegenerative Disease, Charlestown, MA, USA.
Department of Neurology, The Massachusetts General Hospital and NeuroDiscovery Center, Harvard Medical School, Boston, MA, USA.

Eloise Hudry (E)

Alzheimer Research Unit, The Massachusetts General Hospital Institute for Neurodegenerative Disease, Charlestown, MA, USA.
Department of Neurology, The Massachusetts General Hospital and NeuroDiscovery Center, Harvard Medical School, Boston, MA, USA.
Novartis Institute for Biomedical Research, Cambridge, MA, USA.

Bradley T Hyman (BT)

Alzheimer Research Unit, The Massachusetts General Hospital Institute for Neurodegenerative Disease, Charlestown, MA, USA.
Department of Neurology, The Massachusetts General Hospital and NeuroDiscovery Center, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH